1. A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT). (June 2022) Authors: Stroes, Charlotte I; Schokker, Sandor; Khurshed, Mohammed; van der Woude, Stephanie O; Mathôt, Ron AA; Slingerland, Marije; de Vos-Geelen, Judith; Zucchetti, Massimo; Matteo, Cristina; van Dijk, Erik; Ylstra, Bauke; Thijssen, Victor; Derks, Sarah; Godefa, Tesfay; Dijksterhuis, Willemieke; Breimer... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗